Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
about
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitisStrategies to rescue steatotic livers before transplantation in clinical and experimental studiesChronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunctionChemical imaging on liver steatosis using synchrotron infrared and ToF-SIMS microspectroscopiesTranscriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.Oseltamivir treatment prevents the increased influenza virus disease severity and lethality occurring in chronic ethanol consuming miceExposure of precision-cut rat liver slices to ethanol accelerates fibrogenesisAcetaldehyde adducts in alcoholic liver disease.Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Role of Fn14 in acute alcoholic steatohepatitis in mice.Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study.Molecular mechanisms for alcoholic hepatitis based on analysis of gene expression profileEuterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation.Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV.Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China.Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish.What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injuryEffects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease.Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium.Barley Sprouts Extract Attenuates Alcoholic Fatty Liver Injury in Mice by Reducing Inflammatory ResponseA sideways glance. Alcoholic breakdown of barriers: how ethanol can initiate a landslide towards diseasePeroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease.Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients.Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.Hepatoprotective effects of pantothenic acid on carbon tetrachloride-induced toxicity in rats.The de ritis ratio: the test of time.The Ly49E Receptor Inhibits the Immune Control of Acute Trypanosoma cruzi Infection.Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice.Influence of fat/carbohydrate ratio on progression of fatty liver disease and on development of osteopenia in male rats fed alcohol via total enteral nutrition (TEN).Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.Mechanisms of action of acetaldehyde in the up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7Nonalcoholic fatty liver disease: a challenge for pediatricians.Calcium-dependent physiologic and pathologic stimulus-metabolic response coupling in hepatocytes.
P2860
Q26769622-3F6F2A29-96EB-47CE-8381-319F89F038CBQ26991664-394C45ED-E075-4E84-BCEC-2B826AB080B2Q27003912-1FD7D67E-DA70-401F-9779-85D9ABB10F46Q28082228-00C5B8A6-9340-424D-8C15-06EDE7A8E094Q28476303-9B755C06-40D3-4A74-8C2C-B0EA94E8AB6EQ33783707-644870F8-2A1B-4E8F-A074-39938C951FADQ34020714-1FE3CE74-AC3A-4951-A1A1-DAEF5DF2ED4AQ34178813-6E343033-7FF8-4D65-A440-1CE357E20CDFQ34185763-363ECA10-82D6-4CB4-9788-4D4FCAE84414Q34359482-0547C708-4578-438D-B055-25A6D612DBC7Q34750539-EFEDBF51-DC20-4240-A028-4591304F610EQ35086417-01F25FEF-42CA-41B7-AA7D-9E24F0BD6273Q35563896-FF0EA004-9802-43CB-B077-CBBCC8454468Q35671657-BB276A88-5694-4E52-92CD-D9CD954024B4Q35858936-FE913E54-C508-4689-B769-B7D5B9209FB1Q35916623-1AB19BB1-FCF7-4C06-B30A-6FF5A6E52F7FQ36105525-8EF76843-A652-4824-89F2-3551F3CACF4BQ36105896-A584F758-E9AF-45B9-B329-54E18C63A693Q36227409-CBE7196D-7691-47AB-B16B-8B9867697EA2Q36278360-5D458B84-6645-4A58-8A7F-84AE8615D403Q36616784-34BB614A-944B-449F-A438-3EB62463F478Q36774034-3E458522-25FA-42E7-8553-7128EB7E4DCFQ37015293-184624A3-1DAA-4648-8CA1-FE418357434CQ37037647-98AED9EE-DB9F-4ABF-A5FF-22E8A7838CBCQ37133129-36CB9210-6CD5-429C-A8F4-DF79D8E6D09EQ37213121-90A27A37-D6EA-401C-B4BF-BD06FB3E675AQ37346501-502D4CDF-7D16-4C9E-947A-E08D94AB1D3BQ37386694-99B1A813-17D0-4E8C-87D8-52BA1EB896A9Q37397018-F8B340F6-3316-4036-AAA9-5B30E2E875D4Q37400223-EE777F17-586E-4E0D-97B5-DD690270C0E4Q37400943-8A3BA761-87A8-4DC3-ACFF-D8BAB1FD262FQ37406176-BF4F4D0C-35C9-49C3-BCBE-D11B900060D6Q37416581-57EA24B5-55C0-4B59-852E-131972DD2229Q37438010-B9ED4AAB-DEE7-424B-9AE1-AF92883DF909Q37438265-8378EC0F-02BF-4BFF-AC0C-D4B0EBF9C8B7Q37673348-93B690A3-C81B-4416-9484-D7A780BE369FQ37723991-B2AD69BC-E30B-45C4-A000-55B5FBD02E29Q37734889-5F710587-5CE6-4164-B701-D3D5BC52C88EQ37788538-08D55605-47B5-434D-83EC-11A59F41B15DQ38008116-E5179EB8-3BAB-4A43-A1D9-2C45A1371537
P2860
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@en
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@nl
type
label
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@en
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@nl
prefLabel
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@en
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@nl
P2093
P356
P1476
Common pathogenic mechanism in ...... or alcoholic steatohepatitis.
@en
P2093
Hiroyuki Suzuki
Kiyoshi Nagata
Shuhei Sakaguchi
P304
P356
10.2131/JTS.32.453
P577
2007-12-01T00:00:00Z